Cited by 59Lipid metabolism and biosynthesisAdipose Tissue and MetabolismAdipokines, Inflammation, and Metabolic Diseases

Intranasal Insulin Suppresses Systemic but Not Subcutaneous Lipolysis in Healthy Humans

Open access
Iwen, K. Alexander, Scherer, Thomas, Heni, Martin, Sayk, Friedhelm, Wellnitz, Toni, Machleidt, Felix, Preissl, Hubert, Häring, Hans-Ulrich +4 more·2014·The Journal of Clinical Endocrinology & Metabolism

Abstract

CONTEXT: Insulin infused into the central nervous system of rats suppresses lipolysis in white adipose tissue, indicating a role of brain insulin in regulating systemic lipid metabolism. OBJECTIVE: We investigated whether central nervous insulin delivery suppresses lipolysis in healthy humans. DESIGN: Placebo-controlled, balanced within-subject comparisons were performed in both a main and an independent corroborative experiment. SETTING/PARTICIPANTS/INTERVENTION: Two groups of healthy volunteers were examined at the German University Clinics of Lübeck and Tübingen, respectively, with molecular analyses taking place at Mt Sinai School of Medicine (New York, New York). The 14 healthy male subjects of the main study and the 22 women and 5 men of the corroborative study each received 160 IU of human insulin intranasally. MAIN OUTCOME MEASURES: In the main study, we measured systemic levels of free fatty acids (FFAs), triglycerides, and glycerol and the rate of appearance of deuterated glycerol as an estimate of lipolysis before and after intranasal insulin administration. We also analyzed the expression of key lipolytic enzymes in sc fat biopsies and measured blood glucose and glucoregulatory hormones. In the corroborative study, FFA concentrations were assessed before and after intranasal insulin administration. RESULTS: In the main experiment, intranasal insulin suppressed circulating FFA concentrations and lipolysis (rate of appearance of deuterated glycerol) in the absence of significant changes in circulating insulin levels. Lipolytic protein expression in sc adipose tissue was not affected. The corroborative study confirmed that intranasal insulin lowers systemic FFA concentrations. CONCLUSIONS: Our findings indicate that brain insulin controls systemic lipolysis in healthy humans by predominantly acting on non-sc adipose tissue.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/jc.2013-3169

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • IN delivery of 160 IU insulin reduces systemic lipolysis in healthy male individuals.

    “Evidence for complementary functions of peripheral and CNS insulin in the regulation of whole-body energy homeostasis was also obtained in experiments showing that the IN delivery of 160 IU of insulin reduces systemic lipolysis in healthy male individuals.”

    From Intranasal insulin (2021) · cites this paper as [93]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Iwen, K. A., Scherer, T., Heni, M., Sayk, F., Wellnitz, T., Machleidt, F., Preissl, H., Häring, H.-U., Fritsche, A., Lehnert, H., Buettner, C., & Hallschmid, M.
Affiliations
  • University of Lübeck (DE)
  • Medical University of Vienna (AT)
  • Helmholtz Munich (DE)
  • Icahn School of Medicine at Mount Sinai (US)
Corresponding author
  • Buettner, Christoph
  • Hallschmid, Manfred
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
2014-02-01
Volume
99
Issue
2
Pages
E246-E251
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W2029616112
Cited by
59
References
20
Citations by year
2026: 1 · 2025: 1 · 2024: 4 · 2023: 2 · 2022: 6 · 2021: 7 · 2020: 6 · 2019: 4 · 2018: 6 · 2017: 5 · 2016: 6 · 2015: 6 · 2014: 5
FWCI
2.64
Type
journal article
Language
en
Open access
Locations
  • The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • Rutgers University Community Repository (Rutgers University) (submittedVersion)
  • Site cant be reached (submittedVersion)
Funders
National Institute of Diabetes and Digestive and Kidney Diseases (DK083568, R03DK082724, U24DK076169, K08DK074873, DK074873, DK-082724)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
  • Health Sciences › Medicine › Physiology › Adipose Tissue and Metabolism
  • Health Sciences › Medicine › Epidemiology › Adipokines, Inflammation, and Metabolic Diseases
Keywords
intranasal insulin, brain insulin, lipolysis, free fatty acids, subcutaneous adipose tissue, white adipose tissue, lipolytic enzymes, lipid metabolism, glucoregulatory hormones, blood glucose
MeSH terms
Administration, Intranasal, Adult, Blood Glucose, Fatty Acids, Nonesterified, Female, Humans, Insulin, Lipolysis, Male, Subcutaneous Fat

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review